Genetic testing for long QT syndrome and the category of cardiac ion channelopathies
- PMID: 22872816
- PMCID: PMC3392134
- DOI: 10.1371/4f9995f69e6c7
Genetic testing for long QT syndrome and the category of cardiac ion channelopathies
Abstract
Cardiac ion channel mutational analysis is a category of genetic testing used in clinical practice for determining the status of long QT syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tachycardia, and Brugada syndrome genes in blood, saliva, or tissue from patients and family members at risk for cardiac events such as syncope and sudden death. Such testing is most informative following careful phenotypic characterization. Individuals with ion channelopathies may benefit from prevention (avoidance of triggers and predisposing drugs) and treatment (e.g., beta blocker therapy, implantable cardioverter-defibrillator (ICD) placement) modalities.
References
-
- Benito B, Brugada R, Brugada J, Brugada P. Brugada syndrome. Prog Cardiovasc Dis. 2008 Jul-Aug;51(1):1-22. Review. PubMed PMID: 18634914. - PubMed
-
- Heart Rhythm UK Familial Sudden Death Syndromes Statement Development Group. Clinical indications for genetic testing in familial sudden cardiac death syndromes: an HRUK position statement. Heart. 2008 Apr;94(4):502-7. Epub 2007 Jul 30. PubMed PMID: 17664186. - PubMed
-
- Moss AJ. Long QT Syndrome. JAMA. 2003 Apr 23-30;289(16):2041-4. Review. PubMed PMID: 12709446. - PubMed
-
- Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FE, Vignati G, Benatar A, DeLogu A. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002 Jul 2;106(1):69-74. PubMed PMID: 12093772. - PubMed
LinkOut - more resources
Full Text Sources
Medical